{"summary":"\u2022Expertise in drug development \u2013 leading oncology drug\/project teams from research through approval with small molecules and antibody drug conjugates (ADC).\n\u2022High-performing project lead with expertise in managing large multifunctional teams; strategic decision making; regulatory affairs; and resource management.  \n\u2022Skilled strategist who transforms strategic plans into workable solutions and benchmarks performance against key operational targets, goals and timelines.\n*Strong communicator ensuring successful team and stakeholder management.\n\u2022Project Management Professional (PMP) with extensive scope of responsibility and successful track record of delivering results.","lastName":"Kelso","objectUrn":"urn:li:member:6102725","geoRegion":"San Diego, California, United States","fullName":"Kim Kelso","firstName":"Kim","currentPositions":[{"companyName":"Vividion Therapeutics, Inc.","title":"Integrated Product Team Leader","tenureAtCompany":{"numMonths":7},"companyUrnResolutionResult":{"employeeCountRange":"51-200","headquarters":{"geographicArea":"CA","country":"United States","city":"San Diego"},"website":"http:\/\/www.vividion.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/vividion-therapeutics\/","industry":"Biotechnology Research"},"startedOn":{"month":11,"year":2023},"companyUrn":"urn:li:fs_salesCompany:17975374"}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAABdHsUB5P0ZBQdZUvQWyogzCVc0fsKbwHk,NAME_SEARCH,i5Z8)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1647024736973?e=1723075200&v=beta&t=i7vC66f5anE59RNGtV2204F3qdOrdTR-wx37aR7-3UA","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1647024736973?e=1723075200&v=beta&t=4eF8GuMAgmJeqswekrXg6PB2kil7kpo-X4bOz9N7-Xw","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1647024736973?e=1723075200&v=beta&t=1Moh60REKhyrvqky4UkTYmAg8zSlo9F2Q1IZNlcaoFk","height":400},{"width":407,"fileIdentifyingUrlPathSegment":"800_800\/0\/1647024736973?e=1723075200&v=beta&t=IQpD5ynUz2jmyqV8XxQsWG9KMZ-scRORfrfVnnUUnJo","height":407}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/C5603AQFqe3LIfwPDkA\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{"websites":[{"$anti_abuse_annotations":[{"attributeId":97,"entityId":19,"sourceUrn":"urn:li:member:6102725"},{"attributeId":48,"entityId":19,"sourceUrn":"urn:li:member:6102725"}],"category":"COMPANY","dataSource":"LINKEDIN","url":"https:\/\/www.hbanet.org\/"},{"$anti_abuse_annotations":[{"attributeId":97,"entityId":19,"sourceUrn":"urn:li:member:6102725"},{"attributeId":48,"entityId":19,"sourceUrn":"urn:li:member:6102725"}],"category":"COMPANY","dataSource":"LINKEDIN","url":"http:\/\/www.pmi.org\/"}]},"industry":"Pharmaceutical Manufacturing","educations":[{"school":"urn:li:fs_salesSchool:3382","fieldsOfStudy":["Economics & Political Science"],"degree":"BA","schoolUrn":"urn:li:fs_salesSchool:3382","eduId":2482102},{"fieldsOfStudy":["Project Management"],"degree":"PMP","schoolName":"Project Management Institute","eduId":42190340},{"fieldsOfStudy":["Organizational Management"],"degree":"M.A.","schoolName":"University of Phoenix","eduId":39299302}],"skills":[],"numOfConnections":774,"patents":[],"headline":"Integrated Product Team Lead at Vividion Therapeutics, Inc.","courses":[],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/kim-kelso-8050632","organizations":[],"location":"San Diego, California, United States","publications":[],"positions":null,"posts":[{"createdAt":1717175160000,"insightId":"aff9676b-424f-4d8c-b43a-b90a48b49d13","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":5},{"type":"PRAISE","count":5}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7202354672303562752","threadUrn":"urn:li:ugcPost:7202354672303562752","reactionsCount":10,"commentsCount":1,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7202354672303562752","message":{"attributes":[],"text":"So honored to have worked on this program. This is wonderful news for patients!"},"rootActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"VIDEO","thumnailUrl":"https:\/\/dms.licdn.com\/playlist\/vid\/D5605AQG3sZxJX9J7SA\/videocover-firstframe-low\/0\/1717157231475?e=1717977600&v=beta&t=utKSztsG0AVVUTXpNmPP1Wdm7UBIUDwUBrodsLS3Q9E"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7202279389366030336","message":{"attributes":[{"length":7,"start":9,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:asco24"}}},{"length":6,"start":46,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:1185"}}},{"length":6,"start":165,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:nsclc"}}},{"length":24,"start":189,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/gJqBNsfW"}}},{"length":15,"start":948,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:cancerresearch"}}}],"text":"Today at #ASCO24, I am thrilled to share that Pfizer announced a 5-year update from our Phase 3 study, showing unprecedented results for patients with ALK+ advanced #NSCLC. Read more here: https:\/\/lnkd.in\/gJqBNsfW.\n\nALK+ advanced NSCLC is typically aggressive and often impacts younger people in the prime of their lives. I have had the privilege to see how our precision medicines have had a positive impact for patients since the discovery of the first ALK inhibitor more than 10 years ago. The results being presented today, show that a majority of patients are living beyond five years without disease progression, representing Pfizer\u2019s commitment to making significant progress in the treatment of this disease.\n\nThank you to all the Pfizer colleagues, investigators, patients and their families who had a role in the trial and contributed to this milestone. It is a great honor to see the culmination of this work shared with the community.\n\n#CancerResearch"},"entityUrn":"urn:li:ugcPost:7202279389366030336"},"entityUrn":"urn:li:ugcPost:7202354672303562752"}}},{"createdAt":1716490200000,"insightId":"e4fbc58e-682d-418d-8551-b0d3158caa54","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7199422010328846336,7199481894709702656)","threadUrn":"urn:li:ugcPost:7199422010328846336","reactionsCount":1,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations, Tom! They are so lucky to have you on their team!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7199422010328846336"}}},{"createdAt":1715195880000,"insightId":"eb9b1d2a-387e-4b08-b4e4-c95448dcbde3","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7191796432658427904,7194052954205704193)","threadUrn":"urn:li:ugcPost:7191796432658427904","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"We are so lucky to have you on the Vividion team! Very happy to be working with you again."},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7191796432658427904"}}},{"createdAt":1714453140000,"insightId":"ceaca28d-e938-4979-a115-723a93e2d15a","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7190807414638546944,7190937898123190273)","threadUrn":"urn:li:ugcPost:7190807414638546944","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congrats Mustafa!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7190807414638546944"}}},{"createdAt":1714111200000,"insightId":"eb8c7640-4f2b-4b88-89e6-bfc69ec23e45","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7189373142857924609,7189503509954793472)","threadUrn":"urn:li:activity:7189373142857924609","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Awesome!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7189373142857924609"}}},{"createdAt":1711468860000,"insightId":"2539b509-cfae-4f23-91c0-6cd7cc51b56e","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7178400026719649794,7178420801933598725)","threadUrn":"urn:li:activity:7178400026719649794","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations \ud83c\udf89"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7178400026719649794"}}},{"createdAt":1711468860000,"insightId":"bce36d03-9174-456b-96d1-53f14a975263","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7178412689747054593,7178420723458142210)","threadUrn":"urn:li:ugcPost:7178412689747054593","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations, Holly!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7178412689747054593"}}},{"createdAt":1710956820000,"insightId":"7c786dd7-6804-41dd-9190-754afee60aa5","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7175533537419223043,7176273119563718656)","threadUrn":"urn:li:ugcPost:7175533537419223043","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations, Jason!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7175533537419223043"}}},{"createdAt":1710787080000,"insightId":"3fd552ad-2528-47f6-b559-c880d5db4b27","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7175533540980199426,7175561245729705984)","threadUrn":"urn:li:ugcPost:7175533540980199426","reactionsCount":0,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"Congrats, Brooke!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7175533540980199426"}}}]}